• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form 10-K/A filed by American Vanguard Corporation

    5/30/25 6:56:38 PM ET
    $AVD
    Agricultural Chemicals
    Industrials
    Get the next $AVD alert in real time by email
    10-K/A
    trueFY0000005981No00000059812024-01-012024-12-3100000059812025-03-0500000059812024-06-30xbrli:sharesiso4217:USD

     

    f130dli

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 10-K/A

    (Amendment No.1)

     

    ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

    For The Year Ended December 31, 2024

    OR

    ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

    For The Transition Period From To

    Commission file number 001-13795

     

    AMERICAN VANGUARD CORPORATION

     

    Delaware

     

    95-2588080

    (State or other jurisdiction of

    Incorporation or organization)

     

    (I.R.S. Employer

    Identification Number)

     

     

     

    4695 MacArthur Court, Newport Beach, California

     

    92660

    (Address of principal executive offices)

     

    (Zip Code)

    (949) 260-1200

    (Registrant’s telephone number, including area code)

    Securities registered pursuant to Section 12(b) of the Act:

    Title of each class

     

    Trading

    Symbol(s)

     

    Name of each exchange on which registered

    Common Stock, $0.10 par value

     

    AVD

     

    New York Stock Exchange

    Securities registered pursuant to Section 12(g) of the Act:

    NONE

     

    Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

    Indicate by check mark whether the registrant is not required to file reports pursuant to Section 13 or Section 15 (d) of the Act. Yes ☐ No ☒

    Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

    Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer

    ☐

    Accelerated filer

    ☒

    Non-accelerated filer

    ☐

    Smaller reporting company

    ☐

     

     

     

     

    Emerging growth company

     

    ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

    Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒

    If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

     

    Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b).

     

    ☐Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

    The aggregate market value of the voting stock of the registrant held by non-affiliates is $240.6 million. This figure is estimated as of June 30, 2024 at which date the closing price of the registrant’s Common Stock on the New York Stock Exchange was $8.60 per share. For purposes of this calculation, shares owned by executive officers, directors, and 5% stockholders known to the registrant have been deemed to be owned by affiliates. The number of shares of $0.10 par value Common Stock outstanding as of June 30, 2024, was 34,655,429. The number of shares of $.10 par value Common Stock outstanding as of March 5, 2025 was 28,266,826.

    DOCUMENTS INCORPORATED BY REFERENCE

    None.

     


    AMERICAN VANGUARD CORPORATION

     

    EXPLANATORY NOTE

    On May 29, 2025, American Vanguard Corporation (the “Company”) filed with the Securities and Exchange Commission its Annual Report on Form 10-K (the “Annual Report”) for the fiscal year ended December 31, 2024 (the “Original Form 10-K”). This Amendment No. 1 on Form 10-K/A (this “Amendment No. 1”) is being filed to (i) provide an amended Consent of Deloitte & Touche LLP, the Company’s Independent Registered Public Accounting Firm to correct incorrect dates included in the Consent filed with the Original Form 10-K, and (ii) to amend the cover page of the Original Form 10-K to clarify that no information is being incorporated into Part III of the Annual Report from the Company’s definitive proxy statement relating to its 2025 annual meeting of stockholders, with all such information included directly in the Annual Report.

    No other changes have been made to the Original Form 10-K and in this Amendment No. 1 does not modify, amend or update in any way the financial or other disclosures as presented in the Original Form 10-K. This Amendment No. 1 does not reflect events that may have occurred subsequent to the Original Filing Date.

    Pursuant to Rule 12b-15 under the Securities Exchange Act of 1934, as amended, this Amendment No. 1 contains new certifications pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, which are attached hereto. Because no financial statements have been included in this Amendment No. 1 and this Amendment No. 1 does not contain or amend any disclosure with respect to Items 307 and 308 of Regulation S-K, paragraphs 3, 4, and 5 of the certifications have been omitted. Similarly, because no financial statements have been included in this Amendment No. 1, certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 have been omitted.

     

     


    AMERICAN VANGUARD CORPORATION

     

    EXHIBIT INDEX

     

    Exhibit

    Number

     

    Description of Exhibit

     

     

     

    3.1

     

    Amended and Restated Certificate of Incorporation of American Vanguard Corporation (incorporated by reference to Exhibit 3.1 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2003, filed with the Securities Exchange Commission on March 30, 2004).

     

     

     

    3.2

     

    Certificate of Amendment of Amended and Restated Certificate of Incorporation of American Vanguard Corporation (incorporated by reference to Exhibit 3.2 to the Company’s Quarterly Report on Form 10-Q/A for the period ended June 30, 2004, filed with the Securities Exchange Commission on February 23, 2005).

     

     

     

    3.3

     

    Amended and Restated Bylaws of American Vanguard Corporation dated as of December 5, 2019 (incorporated by reference to Exhibit 99.3 to the Company’s Current Report on Form 8-K, filed with the Securities Exchange Commission on December 10, 2019).

     

     

     

    4.1

     

    Form of Indenture (incorporated by reference to Exhibit 4.4 to the Company’s Registration Statement on Form S-3 (File No. 333-122981) filed with the Securities and Exchange Commission on February 25, 2005).

     

     

     

    4.2

     

    Description of Registrant's Capital Stock as of December 31, 2024*

     

     

     

    10.1†

     

    American Vanguard Corporation Employee Stock Purchase Plan (incorporated by reference to Exhibit A to the Company’s Proxy Statement filed with the Securities and Exchange Commission on April 23, 2018).

     

     

     

    10.2†

     

    American Vanguard Corporation Amended and Restated Stock Incentive Plan as of June 8, 2016 (incorporated by reference to Exhibit A to the Company’s Proxy Statement filed with the Securities and Exchange Commission on April 25, 2016).

     

     

     

    10.3†

     

    Form of Incentive Stock Option Agreement under the American Vanguard Corporation Fourth Amended and Restated Stock Incentive Plan, (incorporated by reference to Exhibit 10.3 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2004, filed with the Securities and Exchange Commission on March 16, 2005).

     

     

     

    10.4†

     

    Form of Non-Qualified Stock Option Agreement under the American Vanguard Corporation Fourth Amended and Restated Stock Incentive Plan, (incorporated by reference to Exhibit 10.4 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2004, filed with the Securities and Exchange Commission on March 16, 2005.

     

     

     

    10.5†

     

    Employment Agreement between American Vanguard Corporation and Eric G. Wintemute dated April 1, 2022 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the Securities Exchange Commission on April 7, 2022).

     

     

     

    10.6†

     

    Form of Change of Control Severance Agreement, dated effective as of January 1, 2004, between American Vanguard Corporation and its executive and senior officers (incorporated by reference to Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2004, filed with the Securities Exchange Commission on May 17, 2004).

     

     

     

    10.8†

     

    Second Amendment to the Change of Control Severance Agreement, dated effective as of July 11, 2008, between American Vanguard Corporation and named executive officers and senior officers (incorporated by reference to Exhibit 99.1 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on July 11, 2008).

     

     

     

    10.9†

     

    Form of Indemnification Agreement between American Vanguard Corporation and its Directors (incorporated by reference to Exhibit 10.7 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2004, filed with the Securities and Exchange Commission on March 16, 2005).

     

     

     

    10.10†

     

    Description of Compensatory Arrangements Applicable to Non-Employee Directors (as set forth on page 41 of the Company’s Proxy Statement which was filed with the Securities and Exchange Commission on April 25, 2024, and incorporated herein by reference).

     


    AMERICAN VANGUARD CORPORATION

     

    Exhibit

    Number

     

    Description of Exhibit

     

     

     

    10.11†

     

    Form of Restricted Stock Agreement between American Vanguard Corporation and named executive officers dated as of November 13, 2020 (incorporated by reference to Exhibit 10.12 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the Securities and Exchange Commission on March 31, 2021).

     

     

     

    10.12†

     

    Form of Performance-Based Restricted Stock Units Award Agreement between American Vanguard Corporation and named executive officer dated as of November 13, 2020 (incorporated by reference to Exhibit 10.14 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the Securities and Exchange Commission on March 31, 2021).

     

     

     

    10.13†

     

    Form of American Vanguard Corporation Amended and Restated Stock Incentive Plan TSR-Based Restricted Stock Units Award Agreement dated June 6, 2013 (incorporated by reference to Exhibit 10.15 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2013, filed with the Securities Exchange Commission on February 28, 2014).

     

     

     

    10.14†

     

    Form of American Vanguard Corporation Amended and Restated Stock Incentive Plan Performance-Based Restricted Stock Units Award Agreement dated June 6, 2013 (incorporated by reference to Exhibit 10.16 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2013, filed with the Securities Exchange Commission on February 28, 2014).

     

     

     

    10.15

     

    Third Amended and Restated Loan and Security Agreement dated as of August 5, 2021, among AMVAC and certain affiliates, on the one hand, and a group of commercial lenders led by BMO Harris Bank, N.A., on the other hand (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 10, 2021).

     

     

     

    10.17

     

    Amendment Number Six to the Third Amended Loan and Security Agreement dated as of November 7, 2023, among AMVAC and certain affiliates, on the one hand, and a group of commercial lenders led by BMO Harris Bank, N.A., on the other hand (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on November 9, 2023).

     

     

     

    10.18

     

    Amendment Number Seven to the Third Amended Loan and Security Agreement dated as of August 8, 2023, among AMVAC and certain affiliates, on the one hand, and a group of commercial lenders led by BMO Harris Bank, N.A., on the other hand (incorporated by reference to Exhibit 10.1 to the Company's Form 10-Q for the quarterly period ended June 30, 2024 filed with the Securities and Exchange Commission on August 9, 2024).

     

     

     

    10.19

     

    Amendment Number Eight to the Third Amended Loan and Security Agreement dated as of March 12, 2025, among AMVAC and certain affiliates on the one hand, and a group of commercial lenders led by BMO Harris Bank, N.A., on the other hand (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K, filed with the Securities Exchange Commission on March 14, 2025).

     

     

     

    10.20

     

     

    Amendment Number Nine to the Third Amended Loan and Security Agreement dated as of March 31, 2025, among AMVAC and certain affiliates on the one hand, and a group of commercial lenders led by BMO Harris Bank, N.A., on the other hand (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K, filed with the Securities Exchange Commission on April 4, 2025).

     

     

     

    10.21†

     

    2022 Stock Incentive Plan, Incentive Stock Option agreement dated as of January 22, 2024 (incorporated by reference to Exhibit 10.21 to the Company's Annual Report on Form 10-K for the year ended December 31, 2023, filed with the Securities and Exchange Commission on March 28, 2024).

     

     

     

    10.22†

     

    2022 Stock Incentive Plan, Incentive Stock Option FMV Agreement dated as of January 22, 2024 (incorporated by reference to Exhibit 10.22 to the Company's Annual Report on Form 10-K for the year ended December 31, 2023, filed with the Securities and Exchange Commission on March 28, 2024).

     

     

     

    10.23†

     

    Transition Agreement, dated as of July 3, 2024, by and between American Vanguard Corporation and Eric G. Wintemute (incorporated by reference to Exhibit 99.2 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on July 9, 2024).

     

     

     

    10.24†

     

    Executive Employment Agreement dated as of December 9, 2024, by and between American Vanguard Corporation and Douglas A. Kaye III (incorporated by reference to Exhibit 10.1 to the Company’s

     


    AMERICAN VANGUARD CORPORATION

     

    Exhibit

    Number

     

    Description of Exhibit

     

     

    Current Report on Form 8-K, filed with the Securities and Exchange Commission on December 6, 2024).

     

     

     

    10.25

     

    Cooperation Agreement dated as of April 15, 2025, by and between American Vanguard Corporation and Eric G. Wintemute (incorporated by reference to Exhibit 10.1 to the Company's current Report on Form 8-K, filed with the Securities and Exchange Commission on April 21, 2025).

     

     

     

    10.26

     

    Amendment Number Eleventh to the Third Amended Loan and Security Agreement dated as of May 27, 2025, among AMVAC and certain affiliates on the one hand, and a group of commercial lenders led by BMO Harris Bank, N.A., on the other hand.*

     

     

     

    21

     

    List of Subsidiaries of the Company.*

     

     

     

    23.1

     

    Consent of Deloitte & Touche LLP, Independent Registered Public Accounting Firm**

     

     

     

    23.2

     

    Consent of BDO USA, P.C., Independent Registered Public Accounting Firm.*

     

     

     

    31.1

     

    Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

     

     

     

    31.1.1

     

    Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.**

     

     

     

    31.2

     

    Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

     

     

     

    31.2.1

     

    Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.**

     

     

     

    32.1

     

    Certifications Pursuant to 18 U.S.C. Section 1350 as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*

     

     

     

    97

     

    American Vanguard Corporation Clawback Policy dated as of September 6, 2023 (incorporated by reference to Exhibit 10.21 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the Securities and Exchange Commission on March 28, 2024).

     

     

     

    101.INS

     

    Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.

     

     

     

    101.SCH

     

    Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Document

     

     

     

    104

     

    Cover Page Interactive Data File (embedded within the Inline XBRL document)

    * Previously filed or furnished.

     

    ** Filed herewith.

     

    † Indicates a management contract or compensatory plan.

     

     

     


    AMERICAN VANGUARD CORPORATION

     

    SIGNATURES

    Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, American Vanguard Corporation has duly caused this Amendment to the Registrant’s Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized.

    AMERICAN VANGUARD CORPORATION

    (Registrant)

     

    By:

    /s/ DOUGLAS A. KAYE III

    By:

    /s/ DAVID T. JOHNSON

    Douglas A. Kaye III

    Chief Executive Officer

    David T. Johnson

    Chief Financial Officer

    and Principal Accounting Officer

    May 30, 2025

    May 30, 2025

     


    Get the next $AVD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AVD

    DatePrice TargetRatingAnalyst
    7/22/2024$14.00Buy
    Lake Street
    More analyst ratings

    $AVD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • American Vanguard Receives NYSE Notice Regarding Delayed 10-K Filing

      On April 2, 2025 American Vanguard (NYSE:AVD) (the "Company") received notice from the New York Stock Exchange (the "NYSE") that the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual due to a delay in filing its Annual Report on Form 10-K for the year ended December 31, 2024, with the Securities and Exchange Commission (the "SEC"). The Company determined it would not be able to file the Form 10-K within the 15-day extension period under Rule 12b-25 and needs additional time, resources and effort to complete its year-end reporting process. Accordingly, the Company is working diligently to complete the necessary work to make the filing as soon as possible. T

      4/4/25 4:05:00 PM ET
      $AVD
      Agricultural Chemicals
      Industrials
    • Gabelli Funds to Host 16th Annual Specialty Chemicals Symposium Thursday, March 20, 2025

      GREENWICH, Conn., March 18, 2025 (GLOBE NEWSWIRE) -- Gabelli Funds is hosting its 16th Annual Specialty Chemicals Symposium taking place at The Harvard Club in New York, NY on Thursday, March 20, 2025.  The symposium will draw a variety of companies, with a focus on pricing power, margin recovery, interest rates, inventory stabilization, global trade policy, demand trends, and the M&A environment.  Attendees will also have the opportunity to meet with managements in a one-on-one setting. Agenda: 8:50amOpening Remarks Rosemarie Morbelli, CFA Gabelli Funds   Wayne Pinsent, CFA Gabelli Funds    9:00Arq, Inc. (NASDAQ:ARQ)* Bob Rasmus, President & CEO        9:30BASF Corporation

      3/18/25 8:00:00 AM ET
      $ARQ
      $AVD
      $CC
      $GGZ
      Major Chemicals
      Industrials
      Agricultural Chemicals
      Investment Managers
    • American Vanguard Reports Preliminary Results for Fourth Quarter & Full Year 2024

      Achieved Full-Year Adjusted EBITDA In-Line with Target Range Reduced Inventory by $47 million and reduced Debt by $22 Million in Fourth Quarter 2025 Revenue and Adj. EBITDA Target Range of $565-$585 Million and $45-$52 Million American Vanguard® Corporation (NYSE:AVD), a diversified specialty and agricultural products company that develops, manufactures, and markets solutions for crop protection and nutrition, turf and ornamental management and commercial pest control, today reported preliminary, financial results for the fourth quarter and full year ended December 31, 2024. The results reported herein are preliminary. Final results will appear in the company's 10-K for the fiscal year e

      3/14/25 8:00:00 AM ET
      $AVD
      Agricultural Chemicals
      Industrials

    $AVD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Macicek Steven D bought $71,640 worth of shares (12,000 units at $5.97), increasing direct ownership by 62% to 31,218 units (SEC Form 4)

      4 - AMERICAN VANGUARD CORP (0000005981) (Issuer)

      11/18/24 7:54:49 PM ET
      $AVD
      Agricultural Chemicals
      Industrials
    • Director Rosenbloom Keith M bought $790,844 worth of shares (136,492 units at $5.79) (SEC Form 4)

      4 - AMERICAN VANGUARD CORP (0000005981) (Issuer)

      9/5/24 2:20:02 PM ET
      $AVD
      Agricultural Chemicals
      Industrials
    • Director Rosenbloom Keith M bought $94,595 worth of shares (16,480 units at $5.74) (SEC Form 4)

      4 - AMERICAN VANGUARD CORP (0000005981) (Issuer)

      9/3/24 6:30:08 PM ET
      $AVD
      Agricultural Chemicals
      Industrials

    $AVD
    Leadership Updates

    Live Leadership Updates

    See more
    • American Vanguard Appoints Industry Veteran, Douglas A. ("Dak") Kaye, III as Chief Executive Officer

      Well-positioned to further accelerate transforming the global Company into an efficient, profitable, customer-centric organization American Vanguard® Corporation (AVD), a leading manufacturer and marketer of innovative solutions for the ag industry in the areas of crop protection and nutrition, turf and ornamental management, and commercial pest control (the "Company"), today announced the appointment of Douglas A. ("Dak") Kaye, III as the new Chief Executive Officer following a unanimous vote from its Board of Directors (the "Board"), effective December 9, 2024. Mr. Kaye will be based at global headquarters beginning January 6, 2025. Mr. Kaye brings extensive experience to AVD and is exp

      12/5/24 9:00:00 AM ET
      $AVD
      Agricultural Chemicals
      Industrials
    • American Vanguard Announces Voting Results of Its 2024 Annual Meeting of Stockholders

      American Vanguard Corporation (NYSE:AVD) today announced voting results from its Annual Meeting of Stockholders held on June 6, 2024. As to the first of three initiatives, the nine director nominees named in the proxy received more votes "for" than "against"; those persons are, Marisol Angelini, Scott Baskin, Mark Bassett, Debra Edwards, Emer Gunter, Patrick Gottschalk, Steven Macicek, Keith Rosenbloom and Eric Wintemute. They will serve as directors until the next Annual Meeting of Stockholders or until their successors are duly elected and qualified. In addition, the balance of the initiatives appearing on the Company's proxy passed, namely, the ratification of the appointment of Deloitte

      6/11/24 9:00:00 AM ET
      $AVD
      Agricultural Chemicals
      Industrials
    • American Vanguard Announces Retirement of COO

      American Vanguard Corporation (NYSE:AVD) today announced that, after 35 years in the agrochemical industry, Executive Vice President & Chief Operating Officer, Bob Trogele, will be retiring effective May 31, 2024. Mr. Trogele joined the company's principal operating subsidiary, AMVAC, in January 2015 to focus on growing the business across multiple product lines and geographies, achieving greater profitability, and establishing a pipeline of future opportunities through innovation and strategic relationships. Chairman & CEO, Eric G. Wintemute stated, "Bob's tenure at AMVAC has been marked by remarkable achievements and steadfast dedication. His vision and expertise have been instrumental

      5/29/24 4:05:00 PM ET
      $AVD
      Agricultural Chemicals
      Industrials

    $AVD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by American Vanguard Corporation

      SC 13G/A - AMERICAN VANGUARD CORP (0000005981) (Subject)

      11/14/24 7:00:30 AM ET
      $AVD
      Agricultural Chemicals
      Industrials
    • Amendment: SEC Form SC 13G/A filed by American Vanguard Corporation

      SC 13G/A - AMERICAN VANGUARD CORP (0000005981) (Subject)

      10/31/24 11:54:57 AM ET
      $AVD
      Agricultural Chemicals
      Industrials
    • SEC Form SC 13G filed by American Vanguard Corporation

      SC 13G - AMERICAN VANGUARD CORP (0000005981) (Subject)

      7/11/24 10:46:25 AM ET
      $AVD
      Agricultural Chemicals
      Industrials

    $AVD
    Financials

    Live finance-specific insights

    See more
    • American Vanguard Reports Preliminary Results for Fourth Quarter & Full Year 2024

      Achieved Full-Year Adjusted EBITDA In-Line with Target Range Reduced Inventory by $47 million and reduced Debt by $22 Million in Fourth Quarter 2025 Revenue and Adj. EBITDA Target Range of $565-$585 Million and $45-$52 Million American Vanguard® Corporation (NYSE:AVD), a diversified specialty and agricultural products company that develops, manufactures, and markets solutions for crop protection and nutrition, turf and ornamental management and commercial pest control, today reported preliminary, financial results for the fourth quarter and full year ended December 31, 2024. The results reported herein are preliminary. Final results will appear in the company's 10-K for the fiscal year e

      3/14/25 8:00:00 AM ET
      $AVD
      Agricultural Chemicals
      Industrials
    • American Vanguard Announces Date of Fourth Quarter 2024 Earnings Release and Webcast Conference Call

      American Vanguard® Company (NYSE:AVD) announced today it will release financial results for the fourth quarter of 2024 on Friday, March 14, 2025, before the market opens. The company will conduct a conference call focusing on operating performance and financial results at 9:00 a.m. ET / 6:00 a.m. PT on Friday, March 14, 2025. The conference call will be webcast live via, available in the News and Media section of the Company's website at www.american-vanguard.com or through the following link: https://www.webcaster4.com/Webcast/Page/3070/52044 If you are unable to listen live, the conference call will be archived on the Company's website: www.american-vanguard.com/investors About Amer

      2/28/25 9:00:00 AM ET
      $AVD
      Agricultural Chemicals
      Industrials
    • American Vanguard Reports Third Quarter 2024 Results

      Reiterating full-year 2024 Adj. EBITDA guidance Non-Crop Revenues Grew 17%; Green Solutions Revenues Grew 18% Y/o/Y Business transformation continues to accelerate, raising expected annual benefit to $20 million Company reduced debt by $32.5 million American Vanguard® Company, a diversified specialty and agricultural products company that develops, manufactures, and markets solutions for crop protection and nutrition, turf and ornamental management and commercial pest control, today reported financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Financial and Operational Highlights – versus Third Quarter 2023: Net sales of $118.3 million ($130.7 millio

      11/11/24 4:44:00 PM ET
      $AVD
      Agricultural Chemicals
      Industrials

    $AVD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • New insider Straley Jared claimed ownership of 10,000 shares (SEC Form 3)

      3 - AMERICAN VANGUARD CORP (0000005981) (Issuer)

      3/19/25 6:05:35 AM ET
      $AVD
      Agricultural Chemicals
      Industrials
    • New insider Gilliam Nolteanous claimed ownership of 4,245 shares (SEC Form 3)

      3 - AMERICAN VANGUARD CORP (0000005981) (Issuer)

      3/18/25 1:28:25 PM ET
      $AVD
      Agricultural Chemicals
      Industrials
    • New insider Dipaola Michael Joseph claimed ownership of 10,000 shares (SEC Form 3)

      3 - AMERICAN VANGUARD CORP (0000005981) (Issuer)

      3/18/25 1:26:25 PM ET
      $AVD
      Agricultural Chemicals
      Industrials

    $AVD
    SEC Filings

    See more
    • Amendment: SEC Form 10-K/A filed by American Vanguard Corporation

      10-K/A - AMERICAN VANGUARD CORP (0000005981) (Filer)

      5/30/25 6:56:38 PM ET
      $AVD
      Agricultural Chemicals
      Industrials
    • SEC Form DEF 14A filed by American Vanguard Corporation

      DEF 14A - AMERICAN VANGUARD CORP (0000005981) (Filer)

      5/29/25 5:30:37 PM ET
      $AVD
      Agricultural Chemicals
      Industrials
    • SEC Form 10-K filed by American Vanguard Corporation

      10-K - AMERICAN VANGUARD CORP (0000005981) (Filer)

      5/29/25 9:15:28 AM ET
      $AVD
      Agricultural Chemicals
      Industrials

    $AVD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Lake Street initiated coverage on American Vanguard with a new price target

      Lake Street initiated coverage of American Vanguard with a rating of Buy and set a new price target of $14.00

      7/22/24 8:25:03 AM ET
      $AVD
      Agricultural Chemicals
      Industrials